1IH9 | pdb_00001ih9

NMR Structure of Zervamicin IIB (peptaibol antibiotic) Bound to DPC Micelles


Experimental Data Snapshot

  • Method: SOLUTION NMR
  • Conformers Calculated: 100 
  • Conformers Submitted: 20 
  • Selection Criteria: target function 

wwPDB Validation 3D Report Full Report

Validation slider image for 1IH9

This is version 1.5 of the entry. See complete history

Literature

Spatial Structure of Zervamicin Iib Bound to Dpc Micelles: Implications for Voltage-Gating.

Shenkarev, Z.O.Balashova, T.A.Efremov, R.G.Yakimenko, Z.A.Ovchinnikova, T.V.Raap, J.Arseniev, A.S.

(2002) Biophys J 82: 762

  • DOI: https://doi.org/10.1016/S0006-3495(02)75438-6
  • Primary Citation Related Structures: 
    1IH9

  • PubMed Abstract: 

    Zervamicin IIB is a 16-amino acid peptaibol that forms voltage-dependent ion channels with multilevel conductance states in planar lipid bilayers and vesicular systems. The spatial structure of zervamicin IIB bound to dodecylphosphocholine micelles was studied by nuclear magnetic resonance spectroscopy. The set of 20 structures obtained has a bent helical conformation with a mean backbone root mean square deviation value of approximately 0.2 A and resembles the structure in isotropic solvents (Balashova et al., 2000. NMR structure of the channel-former zervamicin IIB in isotropic solvents. FEBS Lett 466:333-336). The N-terminus represents an alpha-helix, whereas the C-terminal part has a mixed 3(10)/alpha(R) hydrogen-bond pattern. In the anisotropic micelle environment, the bending angle on Hyp10 (23 degrees) is smaller than that (47 degrees) in isotropic solvents. In the NOESY (Nuclear Overhauser Effect Spectroscopy) spectra, the characteristic attenuation of the peptide signals by 5- and 16-doxylstearate relaxation probes indicates a peripheral mode of the peptaibol binding to the micelle with the N-terminus immersed slightly deeper into micelle interior. Analysis of the surface hydrophobicity reveals that the zervamicin IIB helix is amphiphilic and well suited to formation of a tetrameric transmembrane bundle, according to the barrel-stave mechanism. The results are discussed in a context of voltage-driven peptaibol insertion into membrane.


  • Organizational Affiliation
    • Shemyakin-Ovchinnikov Institute of Bioorganic Chemistry, Russian Academy of Sciences, 117997 Moscow, Russia.

Macromolecule Content 

  • Total Structure Weight: 1.82 kDa 
  • Atom Count: 131 
  • Modeled Residue Count: 17 
  • Deposited Residue Count: 17 
  • Unique protein chains: 1

Macromolecules

Find similar proteins by:  Sequence   |   3D Structure  
Entity ID: 1
MoleculeChains  Sequence LengthOrganismDetailsImage
ZERVAMICIN IIB17Emericellopsis salmosynnemataMutation(s): 0 

Small Molecules

Modified Residues  3 Unique
IDChains TypeFormula2D DiagramParent
AIB
Query on AIB
A
L-PEPTIDE LINKINGC4 H9 N O2ALA
DIV
Query on DIV
A
D-PEPTIDE LINKINGC5 H11 N O2

--

HYP
Query on HYP
A
L-PEPTIDE LINKINGC5 H9 N O3PRO
PHL
Query on PHL
A
L-PEPTIDE LINKINGC9 H13 N OPHE

Biologically Interesting Molecules (External Reference) 

1 Unique
Entity ID: 1
IDChains NameType/Class2D Diagram3D Interactions
PRD_000159
Query on PRD_000159
A
Zervamicin IIBPeptaibol / Antibiotic

Experimental Data & Validation

Experimental Data

  • Method: SOLUTION NMR
  • Conformers Calculated: 100 
  • Conformers Submitted: 20 
  • Selection Criteria: target function 

Structure Validation

View Full Validation Report



Entry History 

Deposition Data

Revision History  (Full details and data files)

  • Version 1.0: 2002-02-13
    Type: Initial release
  • Version 1.1: 2011-06-14
    Changes: Version format compliance
  • Version 1.2: 2011-07-13
    Changes: Version format compliance
  • Version 1.3: 2011-07-27
    Changes: Atomic model, Database references, Derived calculations, Non-polymer description, Structure summary
  • Version 1.4: 2012-12-12
    Changes: Other
  • Version 1.5: 2025-03-26
    Changes: Data collection, Database references, Derived calculations, Structure summary